10.07.2015 Views

FGF-signalling in the differentiation of mouse ES cells towards ...

FGF-signalling in the differentiation of mouse ES cells towards ...

FGF-signalling in the differentiation of mouse ES cells towards ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

cell mass regenerates probably through an ability to ‘sense’ <strong>the</strong> total mass <strong>of</strong> <strong>in</strong>sul<strong>in</strong>-produc<strong>in</strong>g<strong>cells</strong> and self-regulate accord<strong>in</strong>gly (Hardikar 2004). Still, <strong>the</strong> success <strong>of</strong> <strong>the</strong>se studies is low andsuch treatments will probably not be sufficient for cur<strong>in</strong>g diabetes.Replacement <strong>the</strong>rapy by external sources <strong>of</strong> β-like <strong>cells</strong> holds <strong>the</strong> potential <strong>of</strong> an <strong>in</strong>f<strong>in</strong>ite supply <strong>of</strong>donor material for transplantation. The <strong>in</strong>itial cell material may come from ei<strong>the</strong>r somatic (oradult) stem <strong>cells</strong> or embryonic stem (<strong>ES</strong>) <strong>cells</strong>, or may <strong>in</strong> time come from patient-specific <strong>in</strong>ducedpluripotent (iPS) <strong>cells</strong>. These cell types are described <strong>in</strong> detail <strong>in</strong> a later section.The immune system represents a major obstacle when discuss<strong>in</strong>g cell replacement-<strong>the</strong>rapies.Patients would ei<strong>the</strong>r have to be put on a life-long treatment <strong>of</strong> immune-suppressive drugs, withmany complications to follow, or o<strong>the</strong>r methods will have to be developed to overcome <strong>the</strong> attack<strong>of</strong> cell material by <strong>the</strong> recipient immune system (Ross<strong>in</strong>i et al. 1999). Encapsulation <strong>of</strong> <strong>the</strong>rapeutic<strong>cells</strong> is one such method. Despite limitations <strong>in</strong> nutrient supply to and transport <strong>of</strong> effectermoleculesfrom <strong>the</strong> transplanted <strong>cells</strong>, studies <strong>in</strong> rat show that <strong>the</strong>y can convey normo-glycaemia<strong>in</strong> steptozotoc<strong>in</strong>-<strong>in</strong>duced diabetic rats (Omer et al. 2005). Ano<strong>the</strong>r possibility is <strong>in</strong>duction <strong>of</strong>immunological tolerance (mixed chimaerism), which has been shown possible by bone-marrowtransplantation <strong>in</strong> mice (Ross<strong>in</strong>i et al. 1999; Blaha et al. 2005).Embryonic developmentTo appreciate <strong>the</strong> challenges <strong>of</strong> directed <strong>in</strong> vitro <strong>differentiation</strong> <strong>of</strong> <strong>ES</strong> <strong>cells</strong>, one must acquire athorough understand<strong>in</strong>g <strong>of</strong> embryonic development. In this <strong>the</strong>sis, focus will be on <strong>mouse</strong>development from zygote to pancreatic β <strong>cells</strong>, especially concentrat<strong>in</strong>g on <strong>the</strong> early development,as <strong>the</strong> work presented here is on <strong>mouse</strong> <strong>ES</strong> cell <strong>differentiation</strong> <strong>in</strong> <strong>the</strong> early steps <strong>towards</strong> β-like<strong>cells</strong>.From zygote to blastocystThe fertilized egg, <strong>the</strong> zygote, is a totipotent cell from which all tissues <strong>of</strong> <strong>the</strong> embryo proper, <strong>the</strong>germ l<strong>in</strong>e and extra-embryonic tissues arise. In mice, <strong>the</strong> zygote moves <strong>in</strong>to <strong>the</strong> uter<strong>in</strong>e tract <strong>of</strong> <strong>the</strong>female and matures along <strong>the</strong> way. By embryonic day 3.5 (E3.5), it has developed <strong>in</strong>to an ovalstructure, <strong>the</strong> blastocyst, consist<strong>in</strong>g <strong>of</strong> an <strong>in</strong>ner cell mass (ICM) at one end and <strong>the</strong> blastocoel at<strong>the</strong> o<strong>the</strong>r end. The ICM gives rise to i) <strong>the</strong> epiblast (also called <strong>the</strong> primitive ectoderm), which willlater form <strong>the</strong> embryo proper and ii) fac<strong>in</strong>g <strong>the</strong> blastocoel, <strong>the</strong> primitive endoderm, which willgive rise to <strong>the</strong> visceral and parietal endoderm (PE), form<strong>in</strong>g parts <strong>of</strong> <strong>the</strong> yolk sac and uter<strong>in</strong>e walll<strong>in</strong><strong>in</strong>g, respectively (Gardner 1983; Rossant 2004). Surround<strong>in</strong>g <strong>the</strong>se structures is <strong>the</strong>trophectoderm (TE), which will develop <strong>in</strong>to <strong>the</strong> foetal parts <strong>of</strong> <strong>the</strong> placenta, <strong>the</strong> chorion. At E4.5<strong>the</strong> blastocyst implants <strong>in</strong>to <strong>the</strong> uter<strong>in</strong>e wall, ga<strong>in</strong><strong>in</strong>g access to maternal blood vessels and <strong>the</strong>rebya supply <strong>of</strong> nutrients and oxygen.The ICM expresses Octamer-4 (Oct4; encoded by Pou5f1), which is down-regulated <strong>in</strong> <strong>the</strong> TE(Nichols et al. 1998) and Nanog, which is ma<strong>in</strong>ta<strong>in</strong>ed <strong>in</strong> <strong>the</strong> epiblast but down-regulated <strong>in</strong> <strong>the</strong> PE(Mitsui et al. 2003). Oct4 –/– and Nanog –/– embryos die due to a failure to form <strong>the</strong> ICM or <strong>the</strong>epiblast, respectively. Also, Sex determ<strong>in</strong><strong>in</strong>g region Y (SRY)-box 2 (Sox2) is present <strong>in</strong> <strong>the</strong> ICM,possibly as remnants <strong>of</strong> maternally deposited prote<strong>in</strong> (Avilion et al. 2003). It is expressed by <strong>the</strong>embryo <strong>in</strong> <strong>the</strong> later epiblast and TE, where it, toge<strong>the</strong>r with OCT4 and nanog <strong>in</strong>ducestranscription <strong>of</strong> pluripotency-associated genes. The TE expresses Cdx2, a homeobox transcriptionfactor, which is required to form <strong>the</strong> placenta and to suppress transcription <strong>of</strong> Oct4 and Nanog(Chawengsaksophak et al. 2004; Strumpf et al. 2005). The PE expresses GATA-b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong> 6(GATA6; (Morrisey et al. 1998)). Recent studies have shown that <strong>cells</strong> <strong>in</strong> <strong>the</strong> ICM express bothnanog and GATA6 prote<strong>in</strong>s prior to segregation <strong>in</strong>to ei<strong>the</strong>r epiblast or PE <strong>cells</strong> <strong>in</strong> a mosaic pattern(Chazaud et al. 2006). It is <strong>the</strong> expression level <strong>of</strong> fibroblast growth factor (<strong>FGF</strong>) that regulateseach cell’s fate <strong>in</strong> such that low levels <strong>of</strong> <strong>FGF</strong> generate epiblast cell formation and high levels <strong>of</strong><strong>FGF</strong> generate PE formation (Yamanaka et al. 2010). At this early stage, <strong>FGF</strong>4 and <strong>FGF</strong> receptor 1(<strong>FGF</strong>R1) are expressed <strong>in</strong> <strong>the</strong> ICM and knockout mice <strong>of</strong> both genes die prior to or at gastrulation(Deng et al. 1994; Yamaguchi et al. 1994; Feldman et al. 1995). Fgf4 expression is activated by6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!